Cleared Traditional

K221058 - LungTrainer (MD2 & MD3) (FDA 510(k) Clearance)

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221058 · Lung Trainers, LLC · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
450d
Days
Class 2
Risk

K221058 is an FDA 510(k) clearance for the LungTrainer (MD2 & MD3). Classified as Spirometer, Therapeutic (incentive) (product code BWF), Class II - Special Controls.

Submitted by Lung Trainers, LLC (Miami, US). The FDA issued a Cleared decision on July 5, 2023 after a review of 450 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5690 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Lung Trainers, LLC devices

Submission Details

510(k) Number K221058 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 11, 2022
Decision Date July 05, 2023
Days to Decision 450 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
311d slower than avg
Panel avg: 139d · This submission: 450d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BWF Spirometer, Therapeutic (incentive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Medical Device Academy, Inc.
Robert Packard

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - BWF Spirometer, Therapeutic (incentive)

All 107
Devices cleared under the same product code (BWF) and FDA review panel - the closest regulatory comparables to K221058.
InSee
K241152 · Tidal Medical Technologies, LLC · Aug 2025
AllPEP
K233855 · Enchant Tek Co. , Ltd. · Feb 2024
Breathe+
K222018 · Peep Medical, LLC Dba Go2 Devices · Jun 2023
Hudson RCI Triflo II Incentive Deep Breathing Exerciser
K220565 · Medline Industries, Inc. · Oct 2022
Pulsehaler
K203378 · Respinova, Ltd. · Mar 2021